{"schema_version":"secwatch.filing_event.v1","accession":"0000896264-25-000119","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2025-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.714848+00:00","generated_at":"2026-05-23T09:51:35.976572+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"USANA Q1 net sales up 10% to $250M; EPS down 43% to $0.49; reiterates FY outlook","bullets":["Net sales $250M (+10% YoY); net earnings $9.4M (-43%); diluted EPS $0.49 vs $0.86.","Adjusted diluted EPS $0.73 (-15%); adjusted EBITDA $30M (-10%).","Direct selling Active Customers 459,000 (-7%); Hiya Active Monthly Subscribers 224,000.","FY2025 outlook reaffirmed: consolidated net sales $920M-$1.0B, diluted EPS $1.50-$2.20.","Repurchased 399,000 shares for $12M; $49M remaining under authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0000896264-25-000119","json":"https://secwatch.observer/filing/0000896264-25-000119.json","markdown":"https://secwatch.observer/filing/0000896264-25-000119.md","text":"https://secwatch.observer/filing/0000896264-25-000119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000119/0000896264-25-000119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000119/usna-20250422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:51:35.976572+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}